138 related articles for article (PubMed ID: 22730905)
21. Reclassifying pT3 renal pelvic urothelial carcinoma with renal parenchyma invasion to pT2 improves correlation with overall survival.
Wu D; Lee CT; Zynger DL
Hum Pathol; 2022 Jul; 125():79-86. PubMed ID: 35307402
[TBL] [Abstract][Full Text] [Related]
22. Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?
Maas M; Mischinger J; Compérat E; Scharpf M; Fend F; Todenhöfer T; Stenzl A; Gakis G; Rausch S
World J Urol; 2021 Nov; 39(11):4021-4027. PubMed ID: 33881556
[TBL] [Abstract][Full Text] [Related]
23. Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis.
Danzig MR; Mallin K; McKiernan JM; Stadler WM; Sridhar SS; Morgan TM; Bochner BH; Lee CT
Cancer; 2018 Jun; 124(12):2507-2514. PubMed ID: 29624636
[TBL] [Abstract][Full Text] [Related]
24. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
Aboumohamed AA; Krane LS; Hemal AK
J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
[TBL] [Abstract][Full Text] [Related]
25. Proposal of an improved prognostic classification for pT3 renal cell carcinoma.
Terrone C; Gontero P; Volpe A; Porpiglia F; Bollito E; Zattoni F; Frea B; Tizzani A; Fontana D; Scarpa RM; Rossetti SR
J Urol; 2008 Jul; 180(1):72-8. PubMed ID: 18485380
[TBL] [Abstract][Full Text] [Related]
26. [Discussion on pT3 staging in TNM staging of AJCC 8(th) edition gallbladder carcinoma].
Yang FC; Li JD; Duan AQ; Bo ZY; Shen NJ; Zhu B; Yu WL; Cui LJ; Wang X; Yu LH; Yin L; Fu XH; Zhang YJ; Qiu YH
Zhonghua Wai Ke Za Zhi; 2019 Nov; 57(11):834-839. PubMed ID: 31694132
[No Abstract] [Full Text] [Related]
27. Prognostic Impact of ALDH1 Expression in Transitional Cell Carcinoma of the Renal Pelvis.
Liu J; Jin J; Yang Y; Han W; Yu W; Shen C; Zhang N; Du P; Zhao Q; Wang S; Tang X
Anticancer Res; 2015 Sep; 35(9):4829-36. PubMed ID: 26254374
[TBL] [Abstract][Full Text] [Related]
28. Impact of p53, MIB-1 and PECAM-1 expression on the prognosis of urothelial carcinoma of the renal pelvis.
García-Tello A; Angulo JC; Andrés G; Ramón de Fata F; Sánchez-Chapado M; López JI
Actas Urol Esp; 2014 Oct; 38(8):506-14. PubMed ID: 24702909
[TBL] [Abstract][Full Text] [Related]
29. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
Bastian PJ; Hutterer GC; Shariat SF; Rogers CG; Palapattu GS; Lotan Y; Vazina A; Amiel GE; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP; Karakiewicz PI;
BJU Int; 2008 Feb; 101(4):450-4. PubMed ID: 17850359
[TBL] [Abstract][Full Text] [Related]
30. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
31. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy.
Thompson RH; Cheville JC; Lohse CM; Webster WS; Zincke H; Kwon ED; Frank I; Blute ML; Leibovich BC
Cancer; 2005 Jul; 104(1):53-60. PubMed ID: 15895375
[TBL] [Abstract][Full Text] [Related]
32. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
33. Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.
Chung PH; Krabbe LM; Darwish OM; Westerman ME; Bagrodia A; Gayed BA; Haddad AQ; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
Urol Oncol; 2014 Oct; 32(7):981-8. PubMed ID: 25022858
[TBL] [Abstract][Full Text] [Related]
34. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival.
Park J; Ha SH; Min GE; Song C; Hong B; Hong JH; Kim CS; Ahn H
J Urol; 2009 Sep; 182(3):894-9. PubMed ID: 19616243
[TBL] [Abstract][Full Text] [Related]
35. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome.
Ficarra V; Novara G; Iafrate M; Cappellaro L; Bratti E; Zattoni F; Artibani W
Eur Urol; 2007 Mar; 51(3):722-9; discussion 729-31. PubMed ID: 16904819
[TBL] [Abstract][Full Text] [Related]
36. pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract.
Langner C; Hutterer G; Chromecki T; Winkelmayer I; Rehak P; Zigeuner R
Mod Pathol; 2006 Feb; 19(2):272-9. PubMed ID: 16424895
[TBL] [Abstract][Full Text] [Related]
37. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
Gupta R; Paner GP; Amin MB
Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
[TBL] [Abstract][Full Text] [Related]
38. [A clinicopathological evaluation of prognostic factors of urothelial tumors of the renal pelvis and ureter].
Oikawa T; Nomura H; Kinsui H; Hamano S; Suzuki N; Tanaka M; Murakami S; Nokubi M; Suzuki Y
Hinyokika Kiyo; 2001 Apr; 47(4):237-40. PubMed ID: 11411096
[TBL] [Abstract][Full Text] [Related]
39. Renal cell carcinoma invading the urinary collecting system: implications for staging.
Uzzo RG; Cherullo E; Myles J; Novick AC
J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
[TBL] [Abstract][Full Text] [Related]
40. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?
Leibovich BC; Cheville JC; Lohse CM; Zincke H; Kwon ED; Frank I; Thompson RH; Blute ML
J Urol; 2005 Mar; 173(3):716-9. PubMed ID: 15711250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
